Y-Intercept (HK)’s Vera Therapeutics VERA Stock Holding History

Y-Intercept (HK)’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-15,391	Closed	-$660K	–	2120
2026 Q2	$660K	Buy	15,391 +3,721	+32%	+$139K	0.01%	1218
2026 Q1	$469K	Sell	11,670 -17,772	-60%	-$766K	0.01%	1269
2025 Q4	$1.49M	Sell	29,442 -37,751	-56%	-$1.34M	0.03%	770
2025 Q3	$1.95M	Buy	+67,193	New	+$1.55M	0.05%	621
2025 Q2	–	Sell	-12,212	Closed	-$293K	–	2046
2025 Q1	$293K	Buy	+12,212	New	+$392K	0.02%	916
2024 Q4	–	Sell	-30,911	Closed	-$1.37M	–	1688
2024 Q3	$1.37M	Buy	30,911 +22,843	+283%	+$867K	0.08%	314
2024 Q2	$292K	Sell	8,068 -6,270	-44%	-$249K	0.02%	1040
2024 Q1	$618K	Buy	+14,338	New	+$511K	0.05%	605

Other funds holding VERA

E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return

MFA Wealth Advisors Pittsburgh, Pennsylvania $589M AUM 19.71% 1-Year Est. Return

Perigon Wealth Management San Francisco, California $6.5B AUM 20.72% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

Y-Intercept (HK)'s VERA Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Vera Therapeutics (VERA) in Q3 2026, closing a stake of 15,391 shares — an estimated $660K sold.

Y-Intercept (HK) first reported a position in VERA in Q1 2024 and held it in 8 quarters. The position peaked at $1.95M in Q3 2025. 19 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

Y-Intercept (HK) reported no remaining Vera Therapeutics position as of Q3 2026 after selling out during the quarter.
Y-Intercept (HK) sold 15,391 Vera Therapeutics shares in Q3 2026, an estimated $660K.
Y-Intercept (HK) first reported a position in Vera Therapeutics in Q1 2024 and held it in 8 quarters.
Y-Intercept (HK)'s Vera Therapeutics position peaked at $1.95M in Q3 2025.
19 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.